Content area


Cannabinoider til behandling af neuropatiske smerter

Lasse Østergaard Andersen, Thomas Peter Enggaard & Jette Højsted Tværfagligt Smertecenter, Rigshospitalet Ugeskr Læger 2018;180:V08170602
Ugeskr Læger 2018;180:V08170602
Blad nummer: 
Cannabinoids for neuropathic pain management
Pharmacological treatment of neuropathic pain is associated with side effects and limited efficacy. Recently, the interest in cannabis-based medicine has led to legalisation of medical cannabis in some countries. The aim of this review is to evaluate the evidence of cannabinoids in neuropathic pain. Seventeen trials were identified; eight reported an analgesic efficacy of cannabis-based medicine, and the remaining trials showed no analgesic efficacy. Conclusions were limited by design of studies and short duration of treatment. Overall, the reduction in pain was minimal.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Birger Kreutzfeldt | 16/09
1 Kommentar
af Thomas Korgaard Jensen | 15/09
1 Kommentar
af Jørgen Larsen | 15/09
12 kommentarer
af Morten Blomgren | 13/09
4 kommentarer
af Frederik Drejer Thrane | 13/09
1 Kommentar